Over-expression of the enzyme prevents the inhibitory effects of accumulated saturated fatty acids on insulin signalling(Chavez et al., 2005) while abnormally high expression of the enzyme has been reported in several human cancers (Park and Schuchman, 2006). The gene discussed is INS; the disease is cancer.